What does the invariant chain do?
The invariant chain (Abbreviated Ii) is a polypeptide which plays a critical role in antigen presentation. It is involved in the formation and transport of MHC class II peptide complexes for the generation of CD4+ T cell responses. The cell surface form of the invariant chain is known as CD74.
What is the difference between HLA and MHC?
“The main difference between the two groups is that MHC is often found in vertebrates, while HLA is only found in humans. To simplify, HLA is the human body’s version of MHC. Part of the responsibility of these antigens is to detect cells entering the body.
What cells express CD74?
CD74 is an integral transmembrane molecule playing a role in intracellular sorting of MHC class II molecules [30, 31]. This molecule is expressed by most of the B-cells, particularly follicular center cells, mantle cells, and activated B-lymphocytes [5, 32].
Which diseases are linked with HLA?
Together with genetic and molecular epidemiology, they have made it possible to establish and hypothesize the plausible mechanisms of association between HLA genetic variants and the pathophysiology of ADs, e.g., rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), type 1 diabetes mellitus (T1D), multiple …
What is HLA antigen?
The human leukocyte antigen (HLA) system or complex is a complex of genes on chromosome 6 in humans which encode cell-surface proteins responsible for the regulation of the immune system. The HLA system is also known as the human version of the major histocompatibility complex (MHC) found in many animals.
Why do T cells need MHC?
T Cells Recognize Foreign Peptides Bound to MHC Proteins The recognition process depends on the presence in the antigen-presenting cell of MHC proteins, which bind these fragments, carry them to the cell surface, and present them there, along with a co-stimulatory signal, to the T cells.
What is CD74 a marker for?
CD74 has been associated with tumor progression and metastasis. Its expression has been suggested to serve as a prognostic factor in many cancers, with higher relative expression behaving as a marker of tumor progression.
